Todos @todosmedical announced game-changing news that in a phase 2 clinical study, #Tollovir, an oral antiviral, showed a 100% reduction in mortality! Superiority to Remdesivir, & takes dying off the table. https://t.co/cu3ysy5E1p @SWReports #Investing

Jon Najarian's Twitter
https://twitter.com/jonnajarian/status/149176...Q&s=19

I think the sponsorship has paid off in the tweet alone.
And building into the weekend.